Citadel Advisors’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31
| Closed | -$44K | – | 5863 |
|
|
2022
Q2 | $44K | Buy |
31
+21
| +210% | +$29.8K | ﹤0.01% | 5539 |
|
|
2022
Q1 | $22K | Sell |
10
-12
| -55% | -$26.4K | ﹤0.01% | 6117 |
|
|
2021
Q4 | $107K | Buy |
22
+11
| +100% | +$53.5K | ﹤0.01% | 5865 |
|
|
2021
Q3 | $68K | Buy |
11
+3
| +38% | +$18.5K | ﹤0.01% | 6021 |
|
|
2021
Q2 | $79K | Buy |
+8
| New | +$79K | ﹤0.01% | 6056 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6246 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$32K | – | 5056 |
|
|
2020
Q3 | $32K | Sell |
5
-2
| -29% | -$12.8K | ﹤0.01% | 4464 |
|
|
2020
Q2 | $51K | Sell |
7
-4
| -36% | -$29.1K | ﹤0.01% | 4369 |
|
|
2020
Q1 | $81K | Buy |
+11
| New | +$81K | ﹤0.01% | 4423 |
|
|
2018
Q2 | – | Sell |
-7
| Closed | -$86K | – | 4159 |
|
|
2018
Q1 | $86K | Sell |
7
-2
| -22% | -$24.6K | ﹤0.01% | 3654 |
|
|
2017
Q4 | $84K | Buy |
+9
| New | +$84K | ﹤0.01% | 3546 |
|
|
2017
Q3 | – | Sell |
-6
| Closed | -$10K | – | 3650 |
|
|
2017
Q2 | $10K | Buy |
+6
| New | +$10K | ﹤0.01% | 3579 |
|
|
2017
Q1 | – | Sell |
-6
| Closed | -$16K | – | 3642 |
|
|
2016
Q4 | $16K | Buy |
+6
| New | +$16K | ﹤0.01% | 3482 |
|
|
2016
Q1 | – | Sell |
-2
| Closed | -$19K | – | 3327 |
|
|
2015
Q4 | $19K | Buy |
+2
| New | +$19K | ﹤0.01% | 3650 |
|